2020 International Society of Hypertension global hypertension practice guidelines - PubMed (original) (raw)

. 2020 Jun;38(6):982-1004.

doi: 10.1097/HJH.0000000000002453.

Claudio Borghi 2, Fadi Charchar 3 4 5, Nadia A Khan 6 7, Neil R Poulter 8, Dorairaj Prabhakaran 9 10 11, Agustin Ramirez 12, Markus Schlaich 13 14, George S Stergiou 15, Maciej Tomaszewski 16 17, Richard D Wainford 18 19 20, Bryan Williams 21, Aletta E Schutte 22 23

Affiliations

• PMID: 32371787
• DOI: 10.1097/HJH.0000000000002453

2020 International Society of Hypertension global hypertension practice guidelines

Thomas Unger et al. J Hypertens. 2020 Jun.

No abstract available

PubMed Disclaimer

Comment in

• 2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence.
  Pareek A, Ram CVS, Joshi S, Mehta RT. Pareek A, et al. J Hypertens. 2020 Nov;38(11):2335-2336. doi: 10.1097/HJH.0000000000002601. J Hypertens. 2020. PMID: 33027113 No abstract available.
• Reply.
  Poulter N, Williams B, Unger T; 2020 ISH Global Hypertension Practice Guidelines Committee. Poulter N, et al. J Hypertens. 2020 Nov;38(11):2336-2337. doi: 10.1097/HJH.0000000000002602. J Hypertens. 2020. PMID: 33027114 No abstract available.
• Reply.
  Schlaich MP, Borghi C, Tomaszewski M, Stergiou GS, Schutte AE, Unger T; 2020 ISH Global Hypertension Practice Guidelines Committee. Schlaich MP, et al. J Hypertens. 2020 Nov;38(11):2339-2340. doi: 10.1097/HJH.0000000000002612. J Hypertens. 2020. PMID: 33027116 No abstract available.
• 2020 International Society of Hypertension global hypertension practice guidelines - lifestyle modification.
  Schneider RH, Salerno J, Brook RD. Schneider RH, et al. J Hypertens. 2020 Nov;38(11):2340-2341. doi: 10.1097/HJH.0000000000002625. J Hypertens. 2020. PMID: 33027117 No abstract available.
• Reply.
  Schutte AE, Charchar F, Prabhakaran D; 2020 ISH Global Hypertension Practice Guidelines Committee. Schutte AE, et al. J Hypertens. 2020 Nov;38(11):2341. doi: 10.1097/HJH.0000000000002626. J Hypertens. 2020. PMID: 33027118 No abstract available.
• Intensive blood pressure-lowering strategy should also be offered to older patients.
  Kow CS, Hasan SS. Kow CS, et al. J Hypertens. 2021 Apr 1;39(4):812-813. doi: 10.1097/HJH.0000000000002778. J Hypertens. 2021. PMID: 33649284 No abstract available.
• Reply.
  Williams B, Unger T, Schutte AE, Tomaszewski M, Poulter NR; 2020 ISH Global Hypertension Practice Guidelines Committee. Williams B, et al. J Hypertens. 2021 Apr 1;39(4):813-814. doi: 10.1097/HJH.0000000000002779. J Hypertens. 2021. PMID: 33649285 No abstract available.

Similar articles

• The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations.
  Verdecchia P, Reboldi G, Angeli F. Verdecchia P, et al. Eur J Intern Med. 2020 Dec;82:1-6. doi: 10.1016/j.ejim.2020.09.001. Epub 2020 Sep 22. Eur J Intern Med. 2020. PMID: 32972800 Review.
• The impact of the 2020 International Society of Hypertension global hypertension practice guidelines on the prevention and control of hypertension in China.
  Li G, Hu R, Zhang X. Li G, et al. Hypertens Res. 2021 Aug;44(8):1040-1041. doi: 10.1038/s41440-021-00649-7. Epub 2021 Apr 6. Hypertens Res. 2021. PMID: 33824488 No abstract available.
• 2020 International Society of Hypertension Global Hypertension Practice Guidelines.
  Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. Unger T, et al. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6. Hypertension. 2020. PMID: 32370572 No abstract available.

Cited by

• Hypertension in Cancer Survivors: A Review of the Literature and Suggested Approach to Diagnosis and Treatment.
  Chuquin D, Abbate A, Bottinor W. Chuquin D, et al. J Cardiovasc Pharmacol. 2022 Oct 1;80(4):522-530. doi: 10.1097/FJC.0000000000001342. J Cardiovasc Pharmacol. 2022. PMID: 36027586 Free PMC article. Review.
• Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.
  Savoia C, Volpe M, Kreutz R. Savoia C, et al. Circ Res. 2021 Apr 2;128(7):1062-1079. doi: 10.1161/CIRCRESAHA.121.318054. Epub 2021 Apr 1. Circ Res. 2021. PMID: 33793331 Free PMC article. Review.
• Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment.
  Barochiner J, Aparicio LS, Martínez R, Boggia J. Barochiner J, et al. J Hum Hypertens. 2023 Sep;37(9):775-782. doi: 10.1038/s41371-022-00758-x. Epub 2022 Sep 26. J Hum Hypertens. 2023. PMID: 36163509 Free PMC article.
• Serum amyloid beta 42 levels correlated with metabolic syndrome and its components.
  Li K, Zhou X, Liu Y, Li D, Li Y, Zhang T, Fu C, Li L, Hu Y, Jiang L. Li K, et al. Front Endocrinol (Lausanne). 2024 Feb 8;15:1278477. doi: 10.3389/fendo.2024.1278477. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38405149 Free PMC article.

References

1. 1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36:1953–2041.
2. 1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:1269–1324.
3. 1. Global Burden of Disease Risk Factor CollaboratorsGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1923–1994.
4. 1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016; 134:441–450.
5. 1. Non-communicable Disease Risk Factor CollaborationWorldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389:37–55.

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer